Angiotensin II inhibitory peptide found in the receptor sequence using peptide array

Biochemical and Biophysical Research Communications

Volumn 315, Issue 1, 2004, Pages 22-29

  Kato, Ryuji ^a   Kunimatsu, Mitoshi ^b   Fujimoto, Seigo ^c   Kobayashi, Takeshi ^a   Honda, Hiroyuki ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA WOMEN'S UNIVERSITY   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin II; Antihypertension; AT1 receptor; Cellulose membrane support; High throughput screening; Peptide; Peptide array; Peptide drug; Transmembrane

Indexed keywords

AMINO ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN ANTAGONIST; CELLULOSE; FLUORESCEIN; LIGAND; PEPTIDE; PROTEIN INHIBITOR; RECEPTOR; UNCLASSIFIED DRUG; VALYLVALYLISOLEUCYLVALYLISOLEUCYLTYROSINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BINDING AFFINITY; CONJUGATE; CONTROLLED STUDY; DNA MICROARRAY; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SYNTHESIS; MALE; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; SCREENING; SOLUBILITY;

EID: 0842264849     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.016     Document Type: Article

References (26)

1. Frank R. The SPOT-synthesis technique synthetic peptide arrays on membrane supports - principles and applications. J. Immunol. Methods. 267:2002;13-26.
2. Kramer A., Schneider-Mergener J. Synthesis and screening of peptide libraries on cellulose membrane supports. Methods Mol. Biol. 87:1998;25-39.
3. Wenschuh H., Volkmer-Engert R., Schmidt M., Schulz M., Schneider-Mergener J., Reineke U. Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Biopolymers. 55:2000;188-206.
4. Reimer U., Reineke U., Schneider-Mergener J. Peptide arrays: from macro to micro. Curr. Opin. Biotechnol. 13:2002;315-320.
5. Kramer A., Volkmer-Engert R., Malin R., Reineki U., Schneiider-Mergener J. Simultaneous synthesis of peptide libraries on single resin and continuous cellulose membrane supports: examples for the identification of protein, metal and DNA binding peptide mixtures. Pept. Res. 6:1993;314-319.
6. Weiler J., Gausepohl H., Hauser N., Jansen O.N., Hoheisel J.D. Hybridization based DNA screening on peptide nucleic acid (PNA) oligomer arrays. Nucleic Acids Res. 25:1997;2792-2799.
7. Dekker N., Cox R.C., Kramer R.A., Egmond M.R. Biochemistry. Substrate specificity of the integral membrane protease OmpT determined by spatially addressed peptide libraries. Peptide Res. 40:2001;1694-1701.
8. Dostmann W.R., Taylor M.S., Nickl C.K., Brayden J.E., Frank R., Tegge W.J. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. Proc. Natl. Acad. Sci. USA. 97:2000;14772-14777.
9. Houseman B.T., Huh J.H., Kron S.J., Mrksich M. Peptide arrays for the quantitative evaluation of protein kinase activity. Nat. Biotechnol. 20:2002;270-274.
10. Robertson M.J. Angiotensin antagonists. J. Recept. Signal Transduct. Res. 20:2000;211-234.
11. Guo D.F., Sun Y.L., Hamet P., Inagami T. The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res. 11:2001;165-180.
12. Hunyady L., Balla T., Catt K.J. The ligand binding site of the angiotensin AT1 receptor. Trends Pharmacol. Sci. 17:1996;135-140.
13. Inoue Y., Nakamura N., Inagami T. A review of mutagenesis studies of angiotensin II type1 receptor the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J. Hypertens. 15:1997;703-714.
14. Nikiforovich G.V., Marshall G.R. 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. Biochem. Biophys. Res. Commun. 286:2001;1204-1211.
15. Hein L., Meinel L., Pratt R.E., Dzau V.J., Kobilka B.K. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol. Endocrinol. 11:1997;1266-1277.
16. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
17. Fuchere J.L., Charton M., Kier L.B., Verloop A., Pliska V. Amino acid side chain parameters for correlation studies in biology and pharmacology. Int. J. Peptide Protein Res. 32:1988;269-278.
18. Hjorth S.A., Schambye H.T., Greenlee W.J., Schwartz T.W. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J. Biol. Chem. 269:1994;30953-30959.
19. Noda K., Saad Y., Karnik S.S. Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation. J. Biol. Chem. 270:1995;28511-28514.
20. Yamano Y., Ohyama K., Kikyo M., Sano T., Nakagomi Y., Inoue Y., Nakamura N., Morishima I., Guo D.F., Hamakubo T., Inagami T. Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT1). J. Biol. Chem. 270:1995;14024-14030.
21. Feng Y.H., Noda K., Saad Y., Liu X.P., Husain A., Karnik S.S. The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism. J. Biol. Chem. 270:1995;12846-12850.
22. Joseph M.P., Maigret B., Bonnafous J.C., Marie J., Scheraga H.A. A computer modeling postulated mechanism for angiotensin II receptor activation. J. Protein Chem. 14:1995;381-398.
23. Groblewski T., Maigret B., Nouet S., Larguier R., Lombard C., Bonnafous J.C., Marie J. Amino acids of the third transmembrane domain of the AT1A angiotensin II receptor are involved in the differential recognition of peptide and nonpeptide ligands. Biochem. Biophys. Res. Commun. 209:1995;153-160.
24. Boucard A.A., Wilkes B.C., Laporte S.A., Escher E., Guillemette G., Leduc R. Photolabeling identifies position 172 of the human AT1 receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure. Biochemistry. 39:2000;9662-9670.
25. Perodin J., Deraet M., Auger-Messier M., Boucard A.A., Rihakova L., Beaulieu M.E., Lavigne P., Parent J.L., Guillemette G., Leduc R., Escher E. Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor. Biochemistry. 41:2002;14348-14356.
26. Kato R., Noguchi H., Honda H., Kobayashi T. Hidden Markov model-based approach as the first screening of binding peptides that interact with MHC class II molecules. Enzyme Microb. Technol. 33:2003;472-481.